Executive Report – Assessing the Certificate of Pharmaceutical Product (CPP) requirements for the drug registration processes in the region of the Americas, towards a more timely access to medicines and more convergent regulatory approaches

This document presents a summary of the analysis of the results for the assessment of the
requirements and practices for the acceptance, use and issuance of the Certificate of Pharmaceutical
Product (CPP) as a key document in the regulatory processes of medicine registration in the region
of the Americas, and in the legal basis supporting its use.